Loading...
BLGO logo

BioLargo, Inc.OTCPK:BLGO Stock Report

Market Cap US$67.6m
Share Price
US$0.21
My Fair Value
US$0.32
34.5% undervalued intrinsic discount
1Y-15.7%
7D0.09%
Portfolio Value
View

BioLargo, Inc.

OTCPK:BLGO Stock Report

Market Cap: US$67.6m

BioLargo (BLGO) Stock Overview

BioLargo, Inc. invents, develops, and commercializes various platform technologies. More details

BLGO fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

BLGO Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

US$0.35
FV
37.4% undervalued intrinsic discount
10.85%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
25 days ago author updated this narrative

BioLargo, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for BioLargo
Historical stock prices
Current Share PriceUS$0.22
52 Week HighUS$0.32
52 Week LowUS$0.16
Beta0.11
1 Month Change30.43%
3 Month Change5.34%
1 Year Change-15.67%
3 Year Change-18.13%
5 Year Change36.88%
Change since IPO-68.71%

Recent News & Updates

User avatar

PFAS, Battery Tech And Medical Launches Will Shape Markets

Transformative technologies and strategic partnerships could drive substantial revenue growth and improve net margins by reducing investment risks.

Recent updates

User avatar

PFAS, Battery Tech And Medical Launches Will Shape Markets

Transformative technologies and strategic partnerships could drive substantial revenue growth and improve net margins by reducing investment risks.

Shareholder Returns

BLGOUS ChemicalsUS Market
7D0.09%-1.0%0.5%
1Y-15.7%-4.1%20.8%

Return vs Industry: BLGO underperformed the US Chemicals industry which returned -2.9% over the past year.

Return vs Market: BLGO underperformed the US Market which returned 21.6% over the past year.

Price Volatility

Is BLGO's price volatile compared to industry and market?
BLGO volatility
BLGO Average Weekly Movement6.8%
Chemicals Industry Average Movement6.3%
Market Average Movement6.4%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.0%

Stable Share Price: BLGO has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: BLGO's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a42Dennis Calvertwww.biolargo.com

BioLargo, Inc. invents, develops, and commercializes various platform technologies. The company’s technologies solve challenging environmental problems comprising per - and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. It provides full-service environmental engineering services.

BioLargo, Inc. Fundamentals Summary

How do BioLargo's earnings and revenue compare to its market cap?
BLGO fundamental statistics
Market capUS$67.58m
Earnings (TTM)-US$3.90m
Revenue (TTM)US$14.05m
4.8x
P/S Ratio
-17.3x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
BLGO income statement (TTM)
RevenueUS$14.05m
Cost of RevenueUS$7.67m
Gross ProfitUS$6.38m
Other ExpensesUS$10.28m
Earnings-US$3.90m

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-0.013
Gross Margin45.40%
Net Profit Margin-27.74%
Debt/Equity Ratio37.7%

How did BLGO perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/09/08 20:58
End of Day Share Price 2025/09/05 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

BioLargo, Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Richard RyanOak Ridge Financial Services Group Inc.